Burning mouth syndrome: a discussion of a complex pathology.
Burning mouth syndrome is a complex pathology for which there is very little information about the etiology and pathogenesis. This lack of knowledge leaves patients with suboptimal treatments. This article discusses the existing scientific evidence about this disease. Since topical oral use of clonazepam have been shown to be effective and safe to treat some patients suffering with burning mouth syndrome, formulations including clonazepam are included with this article. Compounding topical preparations of clonazepam offers opportunities for compounding pharmacists to be more involved in improving the quality of life of burning mouth syndrome patients.
Super-Pharm, Petach-Tikvah, Israel. eyalz@super-pharm.co.il
Eyal
E
Zur
D015670:Acupuncture Therapy; D002054:Burning Mouth Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D002998:Clonazepam / Q000627:therapeutic use; D006801:Humans; D017374:Paroxetine / Q000627:therapeutic use; D015995:Prevalence; D008063:Thioctic Acid / Q000627:therapeutic use
D017374:Paroxetine; D002998:Clonazepam; D008063:Thioctic Acid